Search This Blog

Wednesday, February 7, 2024

Vertex Pharmaceuticals Incorporated: Canaccord Genuity downgrades to hold from sell

 price target reduced from USD 378 to USD 332.

https://www.marketscreener.com/quote/stock/VERTEX-PHARMACEUTICALS-IN-11321/

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)